Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
BRAINTREE, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq:MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced it has signed a Settlement Agreement and Release with Empery Asset Master Ltd., Empery Tax Efficient, LP, Empery Tax Efficient II, LP, Hudson Bay Master Fund Ltd. that resolves all claims asserted against the Company by these entities in a lawsuit filed in 2020 relating to a June 2017 securities purchase agreement.
Related news for (MBOT)
- Midday Market Wrap: Spider Silk Strength, Robotics Surge & Autonomous Acceleration Fuel the Afternoon Trade
- Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
- 24/7 Market News Snapshot 08 September, 2025 – Microbot Medical, Inc. Common Stock (NASDAQ:MBOT)
- MoBot alert highlights: NASDAQ: OCTO, NASDAQ: AREB, NASDAQ: CDT, NASDAQ: ACRV, NASDAQ: MBOT (09/08/25 06:00 AM)
- MoBot alert highlights: NASDAQ: AREB, NASDAQ: CDT, NASDAQ: OCTO, NASDAQ: ACRV, NASDAQ: MBOT (09/08/25 05:00 AM)